Delayed listing of new drugs into medical insurance drugs

Domestic pharmaceutical firms are experiencing much difficulties in their marketing activities due to the prolonged grant period of medical insurance price for new drugs ranging from 150 days to 300 days, pharmaceutical sources said recently.

The usual procedures for listing a drug into medical insurance drugs are as follows:

With the acquisition of a product license from the Korea Food ...